BrugadaDrugs.org

Advisory Board

The BrugadaDrugs.org Advisory Board provides consultation and aids in making decisions regarding our drug lists. This includes decisions regarding placing new drugs on our lists, as well as removing or changing the status of drugs.

Board members:

(in alphabetical order)

Ahmad S. Amin, MD
Research fellow
Heart Failure Research Center, Academic Medical Center, University of Amsterdam
Amsterdam, The Netherlands

Martin Borggrefe, MD, PhD
Professor of Cardiology
1st Department of Medicine-Cardiology, University Hospital Mannheim
Mannheim, Germany

Josep Brugada, MD, PhD
Professor of Cardiology
Arrhythmia Section, Cardiovascular Institute, Hospital Clínic, University of Barcelona
Barcelona, Spain

Masayasu Hiraoka, MD, PhD
Professor of Cardiology
Department of Cardiovascular Diseases, Medical Research Institute, Tokyo Medical and Dental University
Tokyo, Japan

Pieter G. Postema, MD
Research fellow, Cardiology resident
Department of Cardiology, Academic Medical Center, University of Amsterdam
Amsterdam, The Netherlands

Silvia G. Priori, MD, PhD
Professor of Molecular Cardiology
Molecular Cardiology, Fondazione Salvatore Maugeri, Department of Cardiology, University of Pavia
Pavia, Italy

Vincent Probst, MD, PhD
Professor of Cardiology
Service de cardiologie du CHU de Nantes
Nantes, France

Dan M. Roden, MD
Professor of Medicine and Pharmacology
Director, Oates Institute for Experimental Therapeutics
Assistant Vice-Chancellor for Personalized Medicine
Vanderbilt University School of Medicine
Nashville, TN, USA

Hanno L. Tan, MD, PhD
Cardiologist
Department of Cardiology, Academic Medical Center, University of Amsterdam
Amsterdam, The Netherlands

Arthur A.M. Wilde, MD, PhD
Professor of Cardiology
Department of Cardiology, Academic Medical Center, University of Amsterdam
Amsterdam, The Netherlands

Christian Wolpert, MD, PhD
Professor of Medicine
Department of Internal Medicine, Cardiology, Nephrology and Intensive Care, Kliniken Ludwigsburg
Ludwigsburg, Germany